Steven Nissen is in the news for his work on new cholesterol drugs targeting PCSK9, which could make heart disease prevention cheaper and easier.
Recent studies reveal significant progress in cardiovascular health, including diet-based treatments for microvascular dysfunction, the impact of light pollution on heart risk, and innovative gene therapies for high cholesterol. These developments could reshape prevention strategies and patient care.